Navigation Links
Cynosure Announces Presentations at Upcoming Investor Conferences
Date:6/2/2009

WESTFORD, Mass., June 2 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Timothy Baker are scheduled to present at the following investor conferences in New York City this month:

  • Gabelli & Company Healthcare Symposium, Tuesday, June 9; the presentation is scheduled to begin at 9:00 a.m. ET.
  • Needham & Co. 8th Annual Life Sciences Conference, Wednesday, June 10; the presentation is scheduled to begin at 1:00 p.m. ET.
  • Jefferies 3rd Annual Healthcare Conference, Thursday, June 18; the presentation is scheduled to begin at 8:30 a.m. ET.

Investors interested in listening to the live webcasts of these presentations should log on to the "Investor Relations" section of Cynosure's website, www.cynosure.com, and click on the link labeled "Events." The presentations also will be archived on the company's website.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair'/>"/>

SOURCE Cynosure, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
2. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
3. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
4. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
5. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
6. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
7. Cynosure Appoints H. Travis Lee as Vice President of Global Marketing
8. Cynosure Announces Schedule of Upcoming Investor Conferences
9. Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy
10. Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... de julio de 2014 ADB International ... ha anunciado hoy una asociación con Austen BioInnovation ... o el Instituto), para el propósito de llevar ... terapia de señal bioeléctrica (el E-QURE BST Device), ... que tiene una importante experiencia en cicatrización de ...
(Date:7/23/2014)... -- regulated information -- UCB today announced an important ... positive topline results from the latest Phase 3 ... to evaluate the efficacy and safety of ... compared to placebo, as adjunctive treatment in adult ... controlled despite treatment with one or two concomitant ...
(Date:7/23/2014)... With the ability to record continuously at over ... 15 minutes, Fastec Imaging has brought the same ease-of-use of ... “Finally, a high speed camera that can be used as ... lives.” proclaims Matt Kearney, VP of Sales for Fastec Imaging. ... and simplify the traditionally complicated workflow of a high speed ...
(Date:7/22/2014)... 2014 (PRWEB) July 23, 2014 ... University. , The goal of the Symposium ... full spectrum of scientists working in the biomaterials ... topics that represent the most promising directions for ...     Provide faculty and government scientists ...
Breaking Biology Technology:ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2
... siRNA Expression Cassettes , ... enormous opportunities to study gene silencing. Unfortunately, , ... is labor and time intensive. , ... Cassette Kits provide a rapid PCR-based method for preparing , ...
... Gene Specific siRNA Controls , ... , research or you are an ... convenience of the Silencer gene specific siRNA , ... contains 50 g of ready-to-use chemically synthesized and gel , ...
... One Step qRT-PCR , ... MMLV reverse transcriptases , Linear quantitation of mRNA targets , ... from as little , as 500 fg total RNA 1/20th of a single cell! ... complete in 15 min , ...
Cached Biology Technology:GENE SILENCING WITH PCR PRODUCTS 2GENE SILENCING WITH PCR PRODUCTS 3GENE SILENCING WITH PCR PRODUCTS 4GENE SILENCING WITH PCR PRODUCTS 5GENE SILENCING WITH PCR PRODUCTS 6GENE SILENCING WITH PCR PRODUCTS 7GENE SILENCING WITH PCR PRODUCTS 8Control Your siRNA Research 2Control Your siRNA Research 3HIGH SENSITIVITY qRT-PCR 2HIGH SENSITIVITY qRT-PCR 3HIGH SENSITIVITY qRT-PCR 4HIGH SENSITIVITY qRT-PCR 5
(Date:7/23/2014)... are crucial for providing essential fatty acids and ... feeding. There has been concern that soybean-based emulsions ... due to its composition. Combination lipid emulsions based ... have been developed to address this concern. , ... that concern may be unwarranted, according to a ...
(Date:7/22/2014)... showed that mutations in prickle genes cause epilepsy, ... by repeated seizures over time. However, the mechanism ... A new University of Iowa study, published online ... National Academy of Sciences , reveals a novel ... have identified the basic cellular mechanism that goes ...
(Date:7/22/2014)... July 14, 2014, by lightning from a weather system that ... four fires: Stokes Fire, Gold Hikes Fire, French Creek Fire ... are now one larger fire. The fires are burning in ... 243,000 acres in size. The present fire situation continues ... and firefighter safety is the priority on the Carlton Complex ...
Breaking Biology News(10 mins):UI study finds potential genetic link between epilepsy and neurodegenerative disorders 2
... development of a first-of-its-kind cloth that releases nitric oxide gas ... diabetes and a wrap to help preserve organs harvested for ... , a bi-weekly journal. Kenneth Balkus and Harvey Liu ... increase blood flow and regulates a range of other body ...
... Scientists in Massachusetts are reporting new evidence that certain high ... diabetic retinopathy, the leading cause of vision loss in people ... in the retina, could lead to new ways to prevent ... in ACS, Journal of Proteome Research , a monthly ...
... CHAMPAIGN, lll. Researchers report that Helicobacter pylori ... harsh environment of the human stomach, directly activates an ... several types of cancer, including gastric cancer. Chronic ... risk factor for several forms of gastric cancer, but ...
Cached Biology News:Team finds link between stomach-cancer bug and cancer-promoting factor 2Team finds link between stomach-cancer bug and cancer-promoting factor 3
Includes PROTEAN II xi Basic unit and IPG conversion kit PROTEAN II XL Cell, wide format, Compatible with ReadyStrip IPG Strips 1.0 mm 165-3188 1.5 mm 165-3189 2.0 mm 165-3190...
... depletion cocktail is tailored to ... suspensions of rat spleen cells. ... StemSep (or compatible 0.5 Tesla) ... T cell content of the ...
F40 piston seals are supplied as 2 seals with a seal tool to service one F40 pump of a BioLogic DuoFlow workstation....
... is tailored to efficiently deplete ... of non-human primate (Rhesus monkey) ... the StemSep (or compatible 0.5 ... achieving a 2.6 Log depletion ...
Biology Products: